James D. Peyton
James D. Peyton publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology and Gastric Cancer Management and Outcomes.
- World rank
- #3,445,769 of 7,710,434 ranked researchers
- Rank in United States
- #966,703 of 1,627,098
- Works
- 30
- Citations
- 466
- Citations per work
- 15.5
What does James D. Peyton research?
James D. Peyton's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (19%), Pharmacology, Toxicology and Pharmaceutics (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1963.0%
- Medicine1963.0%
- Life Sciences621.3%
- Everything else515.7%
- 1Oncology27% of their works
- 2Pulmonary and Respiratory Medicine24% of their works
- 3Molecular Biology19% of their works
- 4Surgery9% of their works
- 5Hepatology3% of their works
- 6Toxicology2% of their works
Research topics
Which keywords describe James D. Peyton's research?
The keywords of their largest research topics: Chemotherapy, EGFR Mutations, Targeted Therapy, Adjuvant Therapy, Endoscopic Resection, Clinical Practice Guidelines, Chemotherapy-Induced Peripheral Neuropathy and Gastric Cancer.
- Protein Folding
- Liver Cancer
- Preoperative Chemoradiotherapy
- KRAS Mutations
- Cetuximab
- Taxanes
- Gastric Cancer
- Clinical Practice Guidelines
- Adjuvant Therapy
- EGFR Mutations
- Chemotherapy
- Targeted Therapy
- Endoscopic Resection
- Chemotherapy-Induced Peripheral Neuropathy
- Molecular Characterization
- CT Screening
- Esophageal Carcinoma
- Lung Cancer
- Hepatocellular Carcinoma
- Molecular Chaperones
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy133 topics
- EGFR Mutations101 topic
- Targeted Therapy101 topic
- Adjuvant Therapy92 topics
- Endoscopic Resection92 topics
- Clinical Practice Guidelines82 topics
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- Gastric Cancer51 topic
- Molecular Characterization51 topic
- Taxanes51 topic
- CT Screening41 topic
- Cetuximab41 topic
- Esophageal Carcinoma41 topic
- KRAS Mutations41 topic
- Lung Cancer41 topic
- Preoperative Chemoradiotherapy41 topic
- Hepatocellular Carcinoma31 topic
- Liver Cancer31 topic
- Molecular Chaperones31 topic
- Protein Folding31 topic
Where does James D. Peyton work?
James D. Peyton's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does James D. Peyton have?
OpenAlex counts 30 works and 466 citations for James D. Peyton, an h-index of 11, ranking #3,445,769 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James D. Peyton. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.